# Hyperprolactinemia and Adrenal Steroidogenesis

> **NCT04146389** · — · TERMINATED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 5 (actual)

## Conditions studied

- Hyperprolactinemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04146389
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-24
- **Primary completion:** 2023-11-06
- **Final completion:** 2023-11-06
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Preliminary analyses of the samples provide no indication for a clinically relevant relationship between hyperprolactinemia and stimulation of adrenal steroidogenesis.
- **Last updated:** 2023-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04146389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04146389, "Hyperprolactinemia and Adrenal Steroidogenesis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04146389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*